Versant Capital Management, Inc Nektar Therapeutics Transaction History

Versant Capital Management, Inc

  • $454 Million
  • Q4 2024

A detailed history of Versant Capital Management, Inc transactions in Nektar Therapeutics stock. As of the latest transaction made, Versant Capital Management, Inc holds 169 shares of NKTR stock, worth $150. This represents 0.0% of its overall portfolio holdings.

Number of Shares
169
Previous 169 -0.0%
Holding current value
$150
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024
SELL
$0.42 - $0.57 $244 - $332
-583 Reduced 77.53%
169 $0
Q1 2023

Apr 10, 2023
SELL
$0.64 - $3.15 $1,415 - $6,967
-2,212 Reduced 74.63%
752 $0
Q4 2022

Jan 25, 2023
BUY
$2.03 - $4.28 $3,680 - $7,759
1,813 Added 157.52%
2,964 $0
Q3 2022

Dec 30, 2022
BUY
$3.04 - $5.14 $1,255 - $2,122
413 Added 55.96%
1,151 $4,000
Q2 2022

Aug 02, 2022
BUY
$3.17 - $6.17 $624 - $1,215
197 Added 36.41%
738 $3,000
Q1 2022

Apr 29, 2022
BUY
$4.16 - $13.72 $2,213 - $7,299
532 Added 5911.11%
541 $3,000
Q1 2020

Apr 17, 2020
SELL
$14.47 - $27.96 $549 - $1,062
-38 Reduced 80.85%
9 $0
Q3 2019

Oct 18, 2019
SELL
$16.91 - $36.27 $405 - $870
-24 Reduced 33.8%
47 $0
Q2 2019

Jul 16, 2019
SELL
$31.0 - $36.3 $5,239 - $6,134
-169 Reduced 70.42%
71 $2,000
Q1 2019

Apr 23, 2019
SELL
$31.58 - $46.35 $30,253 - $44,403
-958 Reduced 99.17%
8 $8,000
Q1 2019

Apr 23, 2019
BUY
$31.58 - $46.35 $7,326 - $10,753
232 Added 2900.0%
240 $8,000
Q4 2018

Jan 29, 2019
SELL
$30.43 - $56.65 $2,403 - $4,475
-79 Reduced 7.56%
966 $31,000
Q3 2018

Oct 15, 2018
SELL
$46.46 - $68.49 $40,838 - $60,202
-879 Reduced 45.69%
1,045 $63,000
Q2 2018

Jul 06, 2018
SELL
$46.25 - $104.45 $8,325 - $18,801
-180 Reduced 8.56%
1,924 $93,000
Q1 2018

Apr 19, 2018
SELL
$57.4 - $108.44 $13,603 - $25,700
-237 Reduced 10.12%
2,104 $223,000
Q4 2017

Apr 19, 2018
BUY
$23.02 - $60.5 $7,389 - $19,420
321 Added 15.89%
2,341 $139,000
Q3 2017

Apr 23, 2018
BUY
$17.79 - $24.0 $15,441 - $20,832
868 Added 75.35%
2,020 $48,000
Q2 2017

Apr 23, 2018
BUY
N/A
437 Added 61.12%
1,152 $22,000
Q1 2017

Apr 23, 2018
BUY
N/A
706 Added 7844.44%
715 $16,000
Q4 2016

Apr 23, 2018
SELL
N/A
-45 Reduced 83.33%
9 $0
Q4 2015

Apr 23, 2018
BUY
N/A
54
54 $0

Others Institutions Holding NKTR

# of Institutions
145
Shares Held
142M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $167M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email